In Syria, 58-66% of breast cancer patients lacked access to advanced diagnostics, radiation, pain meds; 86% faced high medication costs; these barriers contributed to late-stage diagnoses.
Breast cancer patients in conflict-affected Syria face severe systemic, financial, and security barriers that compromise care and contribute to advanced diagnoses.
Absolute Event Rate: 0% vs 0%
Abstract Background: In conflict zones like Syria, accessing cancer care presents immense challenges. However, there is a critical lack of data on the specific barriers patients face. This study aimed to document these obstacles for breast cancer patients in Syria following 14 years of civil war. We surveyed patients presenting for cancer care to better understand the challenges they faced. Methods: This cross-sectional study included adult patients with a confirmed breast cancer diagnosis presenting to Al-Bairouni University Hospital for care. Data was collected through face-to-face interviews using a structured questionnaire adapted for the Syrian context. The survey covered six key areas: Demographic 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS5-11-14.
Al-Bitar et al. (Tue,) reported a other. In Syria, 58-66% of breast cancer patients lacked access to advanced diagnostics, radiation, pain meds; 86% faced high medication costs; these barriers contributed to late-stage diagnoses.